Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Patch for Tendonitis or Bursitis
NCT00640939Phase 3Completed
- Sponsor
- Cerimon Pharmaceuticals, Inc.
- Start
- Dec 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in tendonitis, bursitis and tenosynovitis comparing Diclofenac Sodium Patch with Placebo Patch (2 arms). Primary endpoint: Efficacy of diclofenac at 14 days. Started Dec 2007; status: completed.
02
Drugs
diclofenac
03
Conditions
tendonitisbursitistenosynovitis
Beyond the preview
Go deeper on NCT00640939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640939.